Targeting cyclin-dependent kinases offers new pathways for cancer therapy
Researchers exploring cancer therapies are focusing on cyclin-dependent kinases, or CDKs, which regulate cell division and gene expression.
Structural Biology
Researchers exploring cancer therapies are focusing on cyclin-dependent kinases, or CDKs, which regulate cell division and gene expression.